Latest News about MDMA treatment
Recent news which mentions MDMA treatment
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
March 27, 2024
Tickers
MDXXF
From Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
February 15, 2024
From Benzinga
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
January 08, 2024
From Benzinga
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
December 22, 2023
From Benzinga
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
December 18, 2023
From Benzinga
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
From Benzinga
Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market
November 08, 2023
Tickers
PMBHF
From Benzinga
MindMed Q3 2023: Financials, Business Funded By 2026 If LSD Pipeline Milestones Achieved
November 03, 2023
Tickers
MNMD
From Benzinga
PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment
July 31, 2023
Tickers
PMBHF
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
May 02, 2023
From Benzinga
Bipartisan Letter Calls For Including Active Service Members In Psychedelic-Assisted Therapy Research
April 10, 2023
From Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
March 10, 2023
Tickers
MNMD
From Benzinga
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
March 06, 2023
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
February 13, 2023
From Benzinga
These Two Psychedelics Companies Team Up In An Exclusive Sales Deal, Here Are The Details
November 16, 2022
Tickers
MSSTF
From Benzinga
Clinical Research Comparing Effects Of Novel MDMA Matches In Healthy Patients Begins In Switzerland
September 20, 2022
Tickers
MNMD
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.